COLL COLLEGIUM PHARMACEUTICAL INC Investments/Divestments 8-K Filing 2024 - Authorized Generic Agreement Collegium Pharmaceutical, Inc. entered into an Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for the marketing of authorized generic versions of their Nucynta IR and Nucynta ER products in the United States.Get access to all SEC 8-K filings of the COLLEGIUM PHARMACEUTICAL INC